These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

852 related articles for article (PubMed ID: 17587838)

  • 1. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM; Armario-Hita JC
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
    Fardet L; Dupuy A; Kerob D; Levy A; Allez M; Begon E; Bachelez H; Morel P; Lebbé C
    J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
    Mekkes JR; Bos JD
    Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hidradenitis suppurativa. Response to treatment with infliximab].
    Pedraz J; Daudén E; Pérez-Gala S; Goiriz-Valdés R; Fernández-Peñas P; García-Diez A
    Actas Dermosifiliogr; 2007 Jun; 98(5):325-31. PubMed ID: 17555675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hidradenitis suppurativa responding to treatment with infliximab.
    Lasocki A; Sinclair R; Foley P; Saunders H
    Australas J Dermatol; 2010 Aug; 51(3):186-90. PubMed ID: 20695857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.
    van Rappard DC; Leenarts MF; Meijerink-van 't Oost L; Mekkes JR
    J Dermatolog Treat; 2012 Aug; 23(4):284-9. PubMed ID: 21756155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.
    Gener G; Canoui-Poitrine F; Revuz JE; Faye O; Poli F; Gabison G; Pouget F; Viallette C; Wolkenstein P; Bastuji-Garin S
    Dermatology; 2009; 219(2):148-54. PubMed ID: 19590173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept: effective in the management of hidradenitis suppurativa.
    Cusack C; Buckley C
    Br J Dermatol; 2006 Apr; 154(4):726-9. PubMed ID: 16536817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa.
    van der Zee HH; Boer J; Prens EP; Jemec GB
    Dermatology; 2009; 219(2):143-7. PubMed ID: 19590174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa.
    Giamarellos-Bourboulis EJ; Pelekanou E; Antonopoulou A; Petropoulou H; Baziaka F; Karagianni V; Stavrianeas N; Giamarellou H
    Br J Dermatol; 2008 Mar; 158(3):567-72. PubMed ID: 18076705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hidradenitis suppurativa treated with dapsone: A case series of five patients.
    Kaur MR; Lewis HM
    J Dermatolog Treat; 2006; 17(4):211-3. PubMed ID: 16971313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment.
    Soria A; Canoui-Poitrine F; Wolkenstein P; Poli F; Gabison G; Pouget F; Viallette C; Revuz J
    Dermatology; 2009; 218(2):134-5. PubMed ID: 19060466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases.
    Moschella SL
    Int J Dermatol; 2007 Dec; 46(12):1287-91. PubMed ID: 18173525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa.
    Lesage C; Adnot-Desanlis L; Perceau G; Bonnet M; Palot JP; Bernard P; Reguiaï Z
    Eur J Dermatol; 2012; 22(5):640-4. PubMed ID: 22759562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab.
    Alecsandru D; Padilla B; Izquierdo JA; Fernández-Cruz E; Sánchez-Ramón S
    Arch Dermatol; 2010 Dec; 146(12):1343-5. PubMed ID: 21173317
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular immunoglobulin for recalcitrant suppurative diseases of the skin: a retrospective review of 63 cases.
    Goo B; Chung HJ; Chung WG; Chung KY
    Br J Dermatol; 2007 Sep; 157(3):563-8. PubMed ID: 17627790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of infliximab in hidradenitis suppurativa.
    Paradela S; Rodríguez-Lojo R; Fernández-Torres R; Arévalo P; Fonseca E
    J Dermatolog Treat; 2012 Aug; 23(4):278-83. PubMed ID: 22482700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical treatment of hidradenitis suppurativa: a retrospective study of 93 cases].
    Bordier-Lamy F; Palot JP; Vitry F; Bernard P; Grange F
    Ann Dermatol Venereol; 2008 May; 135(5):373-9. PubMed ID: 18457723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.